BeBright

Indications for use.

• Asthenic and anxious-neurotic disorders: fatigue, fear, anxiety.
• Insomnia, nighttime restlessness in elderly people.
• Prevention of stressful conditions, before surgery or painful diagnostic tests.
• Meniere’s disease, dizziness associated with dysfunction of the vestibular analyzer of various origins.
• Stuttering, tics in children aged 8 to 14 years.
• Prevention of motion sickness (a specific condition characterized by nausea, vomiting, prostration and vestibular dysfunction caused by being in a moving object such as a ship or an aircraft).
• As an auxiliary tool during the treatment of withdrawal symptoms in alcoholism.

Contraindications.

Hypersensitivity to the components of the drug. Acute renal failure. The period of pregnancy and breastfeeding.

Method of administration and dosage.

BeBright is taken orally before meals. The tablet should be swallowed whole with a sufficient amount of water. In order to reduce the irritating effect of phenibut on the gastrointestinal tract, the drug can be taken after a meal.

For asthenic and anxious-neurotic disorders, adults are prescribed 250-500 mg (1-2 tablets) 3 times a day. The highest single dose for adults is 750 mg, for elderly patients – 500 mg.

The course of treatment is 2-3 weeks. If necessary, the course of treatment can be increased to 4-6 weeks.

Children aged 8 to 14 years – 250 mg (1 tablet) 3 times a day.

BeBright 250 mg tablets can be used as an alternative dosage form.

The course of treatment is 2-6 weeks.

Meniere’s disease, dizziness associated with dysfunction of the vestibular analyzer of various origins.

For dizziness associated with dysfunction of the vestibular analyzer of infectious genesis and with Meniere’s disease, the drug is prescribed 750 mg (3 tablets) 3 times a day for 5-7 days, with a decrease in the severity of vestibular disorders – 250-500 mg (1-2 tablets) 3 times a day for 5-7 days, and then 250 mg 1 time a day for 5 days. With a relatively mild course of disease, BeBright is used 250 mg (1 tablet) 2 times a day for 5-7 days, and then 250 mg 1 time a day for 7-10 days.

In case of dizziness associated with dysfunction of the vestibular analyzer of the vascular and traumatic genesis, BeBright is prescribed 250 mg 3 times a day for 12 days.

For the prevention of motion sickness, a dose of BeBright 250-500 mg is prescribed once 1 hour before the scheduled start of rolling or when the first symptoms of motion sickness appear.

To relieve alcohol withdrawal symptoms, the drug in the first days of treatment is prescribed 250-500 mg 3 times during the day and 750 mg at night, with a gradual decrease in the daily dose to the usual for adults.

Children.

The drug can be used in children over 8 years old.